Curated News
By: NewsRamp Editorial Staff
July 14, 2025
GeoVax to Showcase Vaccine and Cancer Therapy Advances at Emerging Growth Conference
TLDR
- GeoVax Labs' upcoming presentation at the Emerging Growth Conference offers investors a strategic advantage by detailing progress on vaccines and therapies with significant market potential.
- GeoVax Labs will discuss the development stages of GEO-MVA, GEO-CM04S1, and Gedeptin®, including Phase 2 trials and regulatory advancements, during their July 16 presentation.
- GeoVax Labs' innovations in vaccines and cancer therapies aim to improve global health by addressing critical gaps in pandemic readiness and treatment options.
- Discover how GeoVax Labs is revolutionizing vaccine and cancer therapy development with their MVA platform and gene-directed enzyme prodrug therapy at the Emerging Growth Conference.
Impact - Why it Matters
This news is significant as it highlights GeoVax's contributions to addressing critical health challenges, including infectious diseases and cancer. The advancements in their vaccine and therapy programs could lead to more effective treatments and prevention strategies, impacting global health security and patient care. The company's focus on immunocompromised individuals and solid tumors addresses unmet medical needs, offering hope for improved outcomes in these vulnerable populations.
Summary
GeoVax Labs, Inc., a clinical-stage biotechnology company, is set to present key updates on its GEO-MVA, GEO-CM04S1, and Gedeptin® programs at the Emerging Growth Conference on July 16, 2025. Chairman and CEO David Dodd will discuss recent advancements and upcoming milestones, including the favorable Scientific Advice from the European Medicines Agency for GEO-MVA, a next-generation Mpox/smallpox vaccine, and the progress of GEO-CM04S1, a multi-antigen COVID-19 vaccine in Phase 2 trials. Additionally, the potential of Gedeptin®, a gene-directed enzyme prodrug therapy for solid tumors, will be highlighted. The presentation will also cover GeoVax's MVA platform and its role in enhancing vaccine supply diversification and pandemic readiness. Interested parties can register to attend the conference and submit questions in advance or during the live session. A replay will be available on www.EmergingGrowth.com and the Emerging Growth YouTube channel.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, GeoVax to Showcase Vaccine and Cancer Therapy Advances at Emerging Growth Conference
